Claire Nowak

AZGUONC-PRODUCTIONwarmup

Journal Issue 7

Overall Survival With Abiraterone Acetate Plus Prednisone in PEACE-1

Journal

Cover Story

SAKK 08/16—Phase 2 Trial of Darolutamide Maintenance in Metastatic Castration Resistant Prostate Cancer Previously Treated With Novel Hormonal Agents and Non-Progressive Disease After Subsequent Treatment With a Taxane

ARCHES—Final Overall Survival Analysis of Androgen Deprivation Therapy Plus Enzalutamide in Metastatic Hormone- Sensitive Prostate Cancer

Nivolumab Combined With Alternatively Scheduled Ipilimumab in First-line Treatment of Patients With Advanced Renal Cell Carcinoma—PRISM

Health-Related Quality of Life, Pain, and Safety Outcomes With 177Lu-PSMA-617 in Patients With mCRPC —VISION

Abiraterone With or Without Enzalutamide Added to Androgen Deprivation Therapy (ADT) Versus ADT Alone in Men with High-Risk, Non-Metastatic (M0) Prostate Cancer— STAMPEDE

ESMO 2021 Annual Meeting Coverage

A Case Study of Recurrent Prostate Cancer

Clinical Case Review

<p>ESMO 2021 Annual Meeting Coverage</p>


Read articles from Issue 7 of the GU Oncology Now Journal.

About Us

Contributors and Partners

Editorial Policy

Advertising

eNewsletters

Calendar

Contact Us

Contribute

MashupMD

Cancer Nursing Today

Urban Health Today

Blood Cancers Today

DocWire News

Knowledge Hubs

Conference Coverage

Roundtable

The Uromigos

Uromigos Live

Localized

mCSPC

CRPC

Diagnostics

Prostate Cancer

Localized Renal Cell Carcinoma

Advanced Renal Cell Carcinoma

nccRCC

Renal Cell Carcinoma

Non-Muscle Invasive Urothelial Carcinoma

Muscle Invasive Urothelial Carcinoma

Advanced Urothelial Carcinoma

Upper Tract Urothelial Carcinoma

Urothelial Carcinoma

Testicular, Penile, and Rare Cancers

Video Insights

The Oncology Brothers

Expert Interviews

Subscribe